Literature DB >> 17595115

Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site.

Marvin T Nieman1, Alvin H Schmaier.   

Abstract

Investigations determined the critical amino acids for alpha-thrombin's interaction with protease-activated receptors 1 and 4 (PAR1 and PAR4, respectively) at the thrombin cleavage site. Recombinant PAR1 wild-type (wt) exodomain was cleaved by alpha-thrombin with a Km of 28 microM, a kcat of 340 s-1, and a kcat/Km of 1.2 x 10(7). When the P4 or P2 position was mutated to alanine, PAR1-L38A or PAR1-P40A, respectively, the Km was unchanged, 29 or 23 microM, respectively; however, the kcat and kcat/Km were reduced in each case. In contrast, when Asp39 at P3 was mutated to alanine, PAR1-D39A, Km and kcat were both reduced approximately 3-fold, making the kcat/Km the same as that of PAR1-wt exodomain. Recombinant PAR4-wt exodomain was cleaved by alpha-thrombin with a Km of 61 microM, a kcat of 17 s-1, and a kcat/Km of 2.8 x 10(5). When the P5 or P4 position was mutated to alanine, PAR4-L43A or PAR4-P44A, respectively, there was no change in the Km (69 or 56 microM, respectively); however, the kcat was lowered in each case (9.7 or 7.7 s-1, respectively). Mutation of the P2 position (PAR4-P46A) also had no effect on the Km but markedly lowered the kcat and kcat/Km approximately 35-fold. PAR1-wt exodomain and P4 and P3 mutants were noncompetitive inhibitors of alpha-thrombin hydrolyzing Sar-Pro-Arg-pNA. However, PAR1-P40A displayed a mixed type of inhibition. Mutation of P4, P3, or P2 had no effect on the Ki. All PAR4 exodomains were competitive inhibitors of alpha-thrombin. Mutation of P5, P4, or P2 had no effect on the Ki. These investigations show that Leu at P4 in PAR1 or P5 in PAR4 critically influences the kinetics of alpha-thrombin binding and cleavage of PAR1 and PAR4 exodomains. It also implies that factors other than the hirudin-like binding region on PAR1 exodomain predominate in influencing PAR1 cleavage on cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595115      PMCID: PMC2553362          DOI: 10.1021/bi700597p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

1.  PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit.

Authors:  S Swift; P J Sheridan; L Covic; A Kuliopulos
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Cathepsin G activates protease-activated receptor-4 in human platelets.

Authors:  G R Sambrano; W Huang; T Faruqi; S Mahrus; C Craik; S R Coughlin
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

4.  The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity.

Authors:  L W Liu; T K Vu; C T Esmon; S R Coughlin
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

5.  Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin.

Authors:  B F Le Bonniec; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries.

Authors:  J L Harris; B J Backes; F Leonetti; S Mahrus; J A Ellman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

7.  PAR3 is a cofactor for PAR4 activation by thrombin.

Authors:  M Nakanishi-Matsui; Y W Zheng; D J Sulciner; E J Weiss; M J Ludeman; S R Coughlin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

8.  Solution composition dependent variation in extinction coefficients for p-nitroaniline.

Authors:  R Lottenberg; C M Jackson
Journal:  Biochim Biophys Acta       Date:  1983-02-15

9.  The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.

Authors:  Marvin T Nieman; Mark Warnock; Ahmed A K Hasan; Fakhri Mahdi; Benedict R Lucchesi; Nancy J Brown; Laine J Murphey; Alvin H Schmaier
Journal:  J Pharmacol Exp Ther       Date:  2004-06-21       Impact factor: 4.030

10.  Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

Authors:  H J Ehrlich; B W Grinnell; S R Jaskunas; C T Esmon; S B Yan; N U Bang
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  20 in total

1.  Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.

Authors:  Prafull S Gandhi; Zhiwei Chen; Enrico Di Cera
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

2.  Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.

Authors:  M T Nieman; F Burke; M Warnock; Y Zhou; J Sweigart; A Chen; D Ricketts; B R Lucchesi; Z Chen; E Di Cera; J Hilfinger; J S Kim; H I Mosberg; A H Schmaier
Journal:  J Thromb Haemost       Date:  2008-02-25       Impact factor: 5.824

3.  Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.

Authors:  Ruchika Sharma; Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Hiep Luu; Khurrum Shahzad; Berend Isermann; William E Smoyer; Marvin T Nieman; Bryce A Kerlin
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

Review 4.  Protease-activated receptor signalling by coagulation proteases in endothelial cells.

Authors:  Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2014-07-03       Impact factor: 5.249

Review 5.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

6.  PAR4 (Protease-Activated Receptor 4): PARticularly Important 4 Antiplatelet Therapy.

Authors:  Xu Han; Marvin T Nieman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02       Impact factor: 8.311

Review 7.  The domino effect triggered by the tethered ligand of the protease activated receptors.

Authors:  Xu Han; Marvin T Nieman
Journal:  Thromb Res       Date:  2020-08-04       Impact factor: 3.944

8.  Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).

Authors:  Michele M Mumaw; Maria de la Fuente; Amal Arachiche; James K Wahl; Marvin T Nieman
Journal:  Thromb Res       Date:  2015-04-09       Impact factor: 3.944

9.  Protease-activated receptor 1 (PAR1) and PAR4 heterodimers are required for PAR1-enhanced cleavage of PAR4 by α-thrombin.

Authors:  Amal Arachiche; Michele M Mumaw; María de la Fuente; Marvin T Nieman
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

10.  Thrombin inhibits nuclear factor kappaB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C.

Authors:  Jong-Sup Bae; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2009-03       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.